Page last updated: 2024-09-03

n-methyl-1-(1,3-benzodioxol-5-yl)-2-butanamine and Amphetamine-Related Disorders

n-methyl-1-(1,3-benzodioxol-5-yl)-2-butanamine has been researched along with Amphetamine-Related Disorders in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Corkery, J; Deluca, P; Ghodse, AH; Oyefeso, A; Schifano, F1

Other Studies

1 other study(ies) available for n-methyl-1-(1,3-benzodioxol-5-yl)-2-butanamine and Amphetamine-Related Disorders

ArticleYear
Ecstasy (MDMA, MDA, MDEA, MBDB) consumption, seizures, related offences, prices, dosage levels and deaths in the UK (1994-2003).
    Journal of psychopharmacology (Oxford, England), 2006, Volume: 20, Issue:3

    Topics: 3,4-Methylenedioxyamphetamine; Amphetamine-Related Disorders; Cause of Death; Crime; Cross-Sectional Studies; Dose-Response Relationship, Drug; Drug and Narcotic Control; Humans; Illicit Drugs; N-Methyl-3,4-methylenedioxyamphetamine; Statistics as Topic; United Kingdom

2006